Here's why the Immutep (ASX:IMM) share price is frozen

The company's shares will remain in a trading halt until Monday or pending a further update.

| More on:
a doctor looking up at question marks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For the second day in a row, the Immutep Ltd (ASX: IMM) share price will be frozen at market open.

Yesterday, Immutep entered a trading halt until Monday's open, or until such time as the company releases further news regarding a capital raise, whichever comes first.

When Immutep shares closed on Wednesday ­– their latest active session ­– they were swapping hands for 62 cents apiece.

Let's take a look at what we know so far of the biotechnology company's capital raise.

New capital raise

According to Immutep, the capital raise will be an institutional placement. However, the company has not yet stated how much it hopes to raise during the activity.

Additionally, Immutep hasn't yet disclosed why it will be conducting the capital raise.

Market watchers will be keeping an eye on the company today, as further details of its latest placement are likely to be announced before Monday's open.

The last institutional placement completed by Immutep took place in August 2020. Through that placement, the company raised $29.6 million by issuing 123.3 million new shares at 24 cents per share to institutional investors.

Immutep's previous capital raise was used to boost its clinical programs budget.

It mostly went towards the ongoing development of the company's IMP123 – a drug that regulates the immune system. However, a portion of the capital raised went towards Immutep's immunosuppressive agonist drug IMP761, which is still in preclinical stages.

Immutep share price snapshot

2021 has been a good year on the ASX so far for Immutep shares.

The Immutep share price is currently 48% higher than it was at the start of this year. It has also gained 305% since this time last year.

The company has a market capitalisation of around $444 million, with approximately 648 million shares outstanding.

Should you invest $1,000 in Immutep Limited right now?

Before you buy Immutep Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Immutep Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Why is this ASX All Ords stock jumping 7% today?

This stock is ending the week strongly. Let's find out what is getting investors excited.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Why is this ASX 200 stock crashing 30% today?

What's going with this stock? Let's find out why its shares are deep in the red.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 114% in a year, why is the Pro Medicus share price leaping higher again on Thursday?

Pro Medicus shares are back in form today and leaping ahead. Here’s why.

Read more »

Two doctors give the thumbs up to an x-ray
Healthcare Shares

Buying the dip: $10,000 invested in Pro Medicus shares on 7 April is now worth…

This healthcare stock has boomed over the past month. 

Read more »

Two doctors wearing white coats look closely at a medical imaging x-ray as the share prices of ASX 200 healthcare shares improve in FY23
Healthcare Shares

Pro Medicus shares climb 33% in less than a month, have I missed the dip?

Pro Medicus shares have soared. Is it the right time to invest?

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords share just rocketed 19% on BIG news

Investors are sending this ASX All Ords share flying on Monday. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Healthcare Shares

Why is this ASX All Ords stock surging 14% today?

This stock is starting the week strongly. But why? Let's find out.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Healthcare Shares

Guess which ASX All Ords stock is rocketing 58% on big US news

What is getting investors excited today? Let's find out.

Read more »